Linked from
The 66 pages that link to Gene therapy, each with the reason it gives.
Horizontal gene transferRelated: Viral vectors deliver therapeutic genes by a designed transfer between cells.
Gene expressionRelated: Therapeutic designs can change expression of a target gene or supply a functional product.
Molecular biologyRelated: It turns knowledge of genes and gene expression into therapeutic intervention.
GeneRelated: Some therapies add, replace, or modify genes to change cell function.
Hematopoietic stem cell transplantationCompared with: Some inherited blood disorders can be treated by modifying a patient's cells rather than using donor cells.
PlasmidRelated: Plasmids can deliver therapeutic genes in some experimental and clinical approaches.
RNA interferenceCompared with: Unlike many gene therapies, RNAi drugs usually suppress expression without replacing a defective gene.
VirusRelated: Viral vectors are tools for delivering therapeutic genes.
Recombinant DNARelated: Some gene therapies use engineered DNA constructs to supply or regulate genetic instructions.
BiotechnologyBroader topic: It uses biological delivery systems to alter or supplement genes for therapeutic effect.
CRISPR-Cas9Related: Cas9 can be used to alter disease-associated sequences in therapeutic settings.
Genetic engineeringRelated: Genetic engineering supplies methods for changing genes in therapeutic cells.
Gene regulatory networkRelated: Therapies can target regulatory genes or alter expression in specific cells.
Regenerative medicineRelated: It can support regeneration by changing cell behavior, but genetic modification alone is not tissue regeneration.
Enzyme replacement therapyCompared with: It aims to make cells produce a therapeutic protein rather than repeatedly infusing it.
CellRelated: Gene therapy targets cells to alter the instructions driving a disease.
Duchenne muscular dystrophyRelated: Micro-dystrophin gene therapies aim to provide muscle cells with instructions for a shortened dystrophin protein.
ImmunodeficiencyRelated: For selected inherited deficiencies, corrected stem cells can rebuild functional immune lineages.
PhenylketonuriaCompared with: Unlike established dietary and drug treatments, it is not routine standard care for phenylketonuria.
Severe combined immunodeficiencyRelated: For selected SCID types, corrected patient stem cells can restore production of the missing protein.
Genetic disorderRelated: Some genetic disorders can be treated by replacing, editing, or regulating genetic material.
Genome editingNarrower topic: Genome editing is one strategy within the broader field of gene therapy.
Paul BergRelated: Gene therapy illustrates a later medical direction made possible by recombinant DNA techniques.
Molecular geneticsRelated: Understanding genes at the molecular level enabled attempts to correct genetic disease.
Biologic therapyCompared with: Unlike most biologics, gene therapy aims to alter cells’ genetic instructions.
LeukodystrophyRelated: Gene therapies have become treatment options for selected leukodystrophies, including metachromatic leukodystrophy.
Lipid nanoparticleNarrower topic: Lipid nanoparticles are one nonviral platform for delivering genetic medicines.
AchromatopsiaRelated: Clinical research investigates gene replacement for specific inherited forms.
Cell therapyCompared with: It can overlap with cell therapy, but its defining intervention is genetic rather than cellular transfer.
Angelman syndromeRelated: UBE3A delivery is being studied as a way to restore gene function in affected neurons.
Antisense oligonucleotideCompared with: Gene therapies often seek durable genetic change, while antisense effects usually depend on continued drug exposure.
BiopharmaceuticalBroader topic: It is a biopharmaceutical approach that acts through genetic material rather than a conventional active ingredient.
Leber's hereditary optic neuropathyNarrower topic: Clinical research has tested gene therapy approaches to address LHON-associated mitochondrial mutations.
Zinc finger nucleaseRelated: Zinc finger nucleases have been developed to modify disease-related genes in cells.
Chronic granulomatous diseaseRelated: Gene addition is being developed to restore NADPH oxidase function in blood-forming cells.
Emmanuelle CharpentierRelated: CRISPR-Cas9 has enabled experimental approaches to correcting disease-causing mutations.
Human enhancementRelated: Gene-editing techniques raise the possibility of changing traits beyond disease treatment.
OsteopetrosisRelated: Gene-based correction could target the inherited defect, but safe durable delivery remains challenging.
TALENRelated: TALEN editing has been investigated as a way to modify therapeutic cells ex vivo.
CiliopathyCompared with: It offers a possible route to treating inherited ciliary defects, but delivery across affected tissues is challenging.
Primary immunodeficiencyRelated: For selected inherited immunodeficiencies, corrected patient cells can restore a missing gene function.
Rett syndromeRelated: MECP2 replacement is under study, but precise dosage control is a major challenge.
TransgenesisCompared with: It also delivers genetic material, but aims to treat patients rather than create transgenic organisms.
Alpha-1 antitrypsin deficiencyRelated: Researchers are investigating ways to restore alpha-1 antitrypsin production.
HematologyRelated: It can address the inherited cause of some blood disorders, but durability and access remain concerns.
Leber congenital amaurosisNarrower topic: The RPE65 treatment established a gene-replacement approach for one molecular subtype.
AdrenoleukodystrophyNarrower topic: Elivaldogene autotemcel is a specific gene therapy developed for selected cerebral cases.
Canavan diseaseRelated: Experimental approaches aim to restore ASPA function or reduce harmful metabolite accumulation.
Epidermolysis bullosaRelated: Clinical approaches aim to restore functional skin proteins in selected EB forms.
Usher syndromeRelated: Researchers are investigating gene-based treatments for specific Usher syndrome subtypes.